As of 2025-09-17, the Relative Valuation of Mirati Therapeutics Inc (MRTX) is (146.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.70 USD, the upside of Mirati Therapeutics Inc based on Relative Valuation is -350.3%.
The range of the Relative Valuation is (146.73) - (152.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 15.1x | 14.5x |
| Forward P/E multiples | 13.8x - 14.7x | 13.9x |
| Fair Price | (146.73) - (152.52) | (146.94) |
| Upside | -350.0% - -359.8% | -350.3% |
| Date | P/E |